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Introduction
Morbidity from diabetes is a consequence of both microvascular 
and macrovascular disease and atherosclerosis remains the most 
important cause of morbidity and mortality in patients with type 2 
diabetes mellitus.1 The Society for Endocrinology, Metabolism and 
Diabetes of South Africa (SEMDSA) published guidelines in 2003 for 
type 2 diabetes care. These guidelines have clear recommendations 
for glycaemic control, blood pressure and lipid goals as well as 
recommendations for the use of aspirin.2 
The risk of stroke and heart disease is two to four times higher 
for people with diabetes. As cardiovascular disease is the ultimate 
cause of death in the overwhelming majority of patients with 
diabetes, blood pressure, lipid, anti-platelet therapy and avoidance 
of smoking are critical components of care. Substantial reduction in 
morbidity and mortality can be achieved with aggressive treatment 
of hypertension, dyslipidaemia, smoking cessation and daily low-
dose aspirin for most patients with type 2 diabetes.3
In 1996 a study conducted at the Johannesburg Hospital concluded 
that the management of type 2 diabetes at the diabetes clinics 
was largely confined to the control of hyperglycaemia.4 SEMDSA 
estimates the prevalence of type 2 diabetes mellitus in South Africa 
to be approximately 13% in the Indian, 3% in the European and 
5-8% in the African population groups.5
The major aim of this study was to determine the number of diabetes 
patients reaching the recommended blood pressure, lipid and 
glycaemic goals as well as to establish the prevalence of obesity in 
patients attending our diabetes clinics.
Subjects and Methods 
The study was conducted between September 2006 and June 2007. 
The sample of 150 patients was calculated with the assistance of 
a biostatistician. Height, weight, waist circumference and blood 
pressure were measured and glycated heamoglobin (HbA1c) and 
fasting lipograms were obtained from patient records, on a random 
sample of type 2 diabetes patients aged 35 years and older attending 
the diabetes clinics at the three academic hospitals served by the 
University of the Witwatersrand namely: Johannesburg, Helen Joseph 
and Chris Hani Baragwanath. The sister in charge on a given day was 
provided with a letter stating the aims of the study and invitation to 
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participate. The sister was requested to randomly pick ten patient 
files. If the patients chosen met the inclusion criteria and were 
willing to participate they were provided with a patient information 
sheet and referred to the doctor in charge of the study.
Blood pressure measurements were done in triplicate by a single 
observer in accordance with the latest South African Hypertension 
Guidelines and The Seventh Report of the Joint National Committee 
on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (JNC VII).6,7 Systolic blood pressure of less than 130 mmHg 
and diastolic blood pressure of less than 80 mmHg (provided no 
proteinuria was present) were used for blood pressure goals as 
recommended by the Society for Endocrinology, Metabolism and 
Diabetes of South Africa (SEMDSA).
Height was measured with the patient barefoot with his/her back 
against the wall in accordance with the guidelines for prevention and 
management of obesity in South Africa.8 Weight was measured with 
a standard, calibrated scale.
Waist circumference was measured with an individual in an upright 
position, in a horizontal plane mid-way between superior iliac 
crest and the rib cage in the mid-axillary line, at the end of normal 
expiration. The International Diabetes Federation (IDF) correlates 
were used to define the Metabolic Syndrome.9 Central obesity was 
defined as waist circumference greater or equal to 94 cm in males 
and 80 cm in females.
Body Mass Index (BMI) was calculated using the Quetelet’s formula- 
weight (kg)/height2 and obesity and overweight was defined using 
the World Health Organization (WHO) classification.
Fasting serum lipograms and glycated haemolglobin using the Tina-
Quant Hemoglobin A1c II immunological assay were also measured. 
SEMDSA guidelines for type 2 diabetes were obtained from patient 
records not also measured. A HbA1c of < 7% was considered optimal, 
7-8% acceptable, and > 8% sub-optimal requiring additional action. 
The ideal recommended fasting lipid profile for a diabetes is a total 
serum cholesterol of < 5, 0 , and LDL cholesterol of < 2, 5, and 
HDL cholesterol of > 1, 2 and serum total triglycerides level of < 1, 
5 mmol/l. The LDL cholesterol level of < 2, 5 mmol/l was adopted 
from the South African Heart Association guidelines in view of the 
fact that current literature supports that lower LDL cut-off may be 
appropriate. 10,11
The study was approved by the Human Research Ethics Committee 
of the University of the Witwatersrand.
Data collected on the patient data sheet was tabulated using Microsoft 
Office Excel 2003. Estimation of the sample size was done assuming 
that LDL-cholesterol is normally distributed in the population. 
A significance level of 5%, precision 0,92 and standard deviation 
5,78 was calculated using the 1996 study. Descriptive statistics were 
used to describe and analyze the data. Means were calculated for 
age, duration of diabetes, BMI, systolic and diastolic blood pressure, 
total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and 
HbA1c. Percentage of patients meeting the recommended goals for 
HbA1c, BMI, waist circumference, blood pressure and lipids were 
also calculated. In addition, calculations looking at the percentage 
of patients following a diabetic diet, smoking trends, lipid-lowering 
therapy usage in the three hospitals including its relation to achieving 
lipid targets, exercise trends (leisure activity), and aspirin usage were 
done. Statistical program used was Stata 10.12
Results
One hundred and fifty patients were collected from the three hospitals 
(each hospital contributing one third of the total). The sample included 
102 (68%) Black patients, 13 (8, 7%) Coloured patients, 16 (10, 7%) 
Indian patients and 19 (12, 7%) White patients. Ninety eight were 
females (65%) and fifty two were males (35%). The mean age of the 
patients was 59, 8 years (SD 10, 77) - (table 1)
Mean HbA1c for the 150 patients was 8, 7% (± 2, 7). Only forty six 
patients (30, 7%) had an HbA1c < 7%.Twenty one patients (14%) 
had an acceptable HbA1c of 7-8% and 83 patients (55, 3%) had an 
unacceptable HbA1c (>8%).
Mean waist circumference was 101, 2 cm (± 13, 5). In the sample 
of 98 female patients only two had a waist circumference of 
< 80 cm. Out of 52 males 36 (69%) had a waist circumference 
≥ 94 cm. Only 41 patients (27, 3%) had an ideal BMI < 25 kg/m2, 
53 patients (35, 3%) were overweight with a BMI between 25-29, 
9 kg/m2 and 56 patients (37, 3%) were obese with a BMI ≥ 30 kg/m2. 
Of the 150 patients, 127 (84, 7%) were known to have hypertension 
and were on treatment. The mean SBP in the hypertensive group 
was 142, 9 mmHg (± 23, 4) and DBP 78, 24 mmHg (± 10, 9). Of 
these, 100 (78, 7%) had a systolic blood pressure (SBP) ≥ 130 mmHg 
and 76 (59, 8%) had a diastolic blood pressure (DBP) ≥ 80 mmHg. 
Mean serum total cholesterol was 4, 5 mmol/l (± 1, 5). One hundred 
and six patients (70, 7%) had a total cholesterol < 5 mmol/l. 
The mean total serum triglycerides value was 1, 6 mmol/l (± 0, 9). 
Eighty two patients (54, 7%) had a triglyceride level of < 1, 5 mmol/l, 
thus meeting the SEMDSA recommendations. Only 44 patients (29, 
3%) were above the recommended HDL level of 1,2 mmol/l. Mean 
low density lipoprotein cholesterol (LDL) level was 2, 6 mmol/l (± 1, 
03). Only seventy five patients (50, 7%) had LDL cholesterol of < 2, 
5 mmol/l.
Leisure activity of the diabetic patients in the cohort was briefly 
looked at. 65 patients (43%) exercised minimally if at all, 32 patients 
exercised seven days per week (21, 3%) and 53 (35, 3%) exercised 
less than the recommended seven days per week. 
Table 1: Demographic data for the study cohort (n=150)
 Variable Mean Std Dev
Age (years) 59.85 10.77
Waist circumference (cm) 101.18 13.51
Height (cm) 113.39 78.51
Weight (kg) 80.24 18.14
Body Mass Index (kg/m2) 29.19 6.56
Systolic Blood Pressure (mmHg) 142.91  23.37
Diastolic Blood Pressure (mmHg) 78.24  10.99
Total Cholesterol (mmol/l) 4.49   1.54
 Triglycerides (mmol/l) 1.56   0.93
High Density Cholesterol (mmol/l) 1.09 0.37
Low Density Cholesterol (mmol/l) 2.59 1.03
Glycated Haemoglobin (%) 8.72 2.73
Gender: Males/Females- 52/98
68% Black patients, 12,7% White patients, 10,7% Indian patients and 8,7% Coloured
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In the SEMDSA guidelines aspirin is recommended as a secondary 
prevention strategy in individuals with evidence of macrovascular 
disease. In the current study 32 patients (21, 3%) had clinical 
evidence of large vessel disease but only 14 out of those 32 patients 
were not on aspirin. 
Further analysis of the data showed that 17 patients (12%) were 
not following a diabetic diet despite the demonstrated benefit. 
123 (82%) of the patients included in the sample denied smoking on 
direct questioning. 9 (6%) of the patients were current smokers and 
18 (12%) were ex-smokers.
Discussion
The Society for Endocrinology, Metabolism and Diabetes of South 
Africa (SEMDSA) publish guidelines for management of type 2 
diabetes.2 These guidelines give clear recommendations as to 
the glycaemic, blood pressure and lipid targets in type 2 diabetes 
patients. The guidelines also provide us with clear management plan 
that one should adopt in order to achieve these targets. In addition 
to glucose, blood pressure and lipid treatment recommendations, 
the guidelines also emphasize aspirin and the importance of 
patient education and nutritional counselling. Diabetes Mellitus was 
considered to be a rare disease in sub-Saharan Africa up to the early 
1960s but over the past few decades it has emerged as a disease of 
significant importance.13,14
In fact diabetes is now an important cause of morbidity and mortality 
in Africa.15
Prevalence and incidence of cardio vascular disease (CVD) is increased 
in patients with type 2 diabetes mellitus and diabetes is associated 
with a two to four fold increase in the risk of developing coronary 
artery disease (CAD). The Steno-2 study showed that target driven, 
long term, intensified intervention aimed at multiple risk factors in 
patients with type 2 diabetes and microalbuminuria can reduce the 
risk of cardiovascular and microvascular events by about 50%. The 
aim of this study was to determine how many diabetes patients 
at our three teaching hospitals, 
attending our diabetes clinics, 
are reaching the recommended 
targets. The results summarised 
in Table 2, clearly indicate that 
despite the available evidence, that 
supports the need for achieving 
recommended targets, the 
management of diabetes patients 
is still largely sub-optimal. 
Obesity remains a major problem 
in our setting in patients with 
diabetes. Only (27%) of the patients 
had a BMI in a normal range. It 
has previously been argued that 
obesity is less “harmful” in black 
women than in other groups. 
However it is now recognized that 
obesity defined as a BMI > 30 kg/
m2, is associated with increased 
risk of many health problems in all 
populations. The term “healthy” 
obesity may therefore no longer be appropriate. Weight loss usually 
reduces the physical, metabolic and psychological hazards facing 
overweight and obese individuals. While BMI provides a guide for 
appropriate weight for height, it does not take into account the effects 
of distribution of body fat. The amount of intra-abdominal fat is a 
better predictor of cardiovascular risk, diabetes and other endocrine 
abnormalities than BMI and waist circumference measurements 
have been shown to be a good indicator of intra-abdominal fat in 
adults. Our results also show that ninety eight percent of South 
African females in the study cohort had a waist circumference above 
the current recommended 80 cm. Sixty nine percent of males had 
waist above 94 cm. However one has to be very cautious with the 
current recommended IDF definition of metabolic syndrome. The 
figures proposed in the worldwide definition of metabolic syndrome 
are a guide for people of European and Indian descent. They have not 
been validated for use in African populations.
Strict blood pressure control is recommended for all type two 
diabetes patients and the South African guidelines emphasise this. 
This means that even stage one hypertension (SBP 140-149 and DBP 
90-99 mmHg) puts a diabetic patient in the moderate risk group with 
stage three hypertension (SBP>180 and DBP>110 mmHg) being a 
very high added risk. Despite these recommendations the majority of 
patients in our study cohort had poorly controlled hypertension.
Lipid management of type 2 diabetes mellitus and the importance 
of reaching recommended targets have also been demonstrated in 
a large number of randomized clinical trials. Since the publication 
of ATP III, five major trials of statin therapy with clinical end-points 
have been published. These trials support inclusion of patients 
with diabetes in the high-risk category and confirm the benefit of 
LDL-lowering therapy in these patients. In high risk patients the 
recommended LDL goal is < 2, 6 mmol/l in SEMDSA and less than 
2, 5 mmol/l using the South African Heart Association guidelines but 
in very high risk patients an LDL goal of less than 1, 8 mmol/l is 
being proposed as a therapeutic option.11 Our results indicate that 
the current SEMDSA guidelines recommended targets are still not 
being met in a significant number of patients. 
In summary the improved knowledge of the cardiovascular risk factor 
identification and management has not been translated into improved 
diabetes care. Significant number of patients are not reaching the 
recommended blood pressure, lipid, BMI, waist circumference and 
glycaemic targets. Emphasis should be placed on education of the 
doctors working in the diabetes clinics to encourage them to adhere 
to current SEMDSA guidelines in order to improve the management 
of the patients at our clinics. Two tertiary care diabetes clinics at 
Kalafong Hospital in Pretoria underwent a quasi-experimental 
controlled before-and –after study. The aim of this study was to 
determine if a physician education programme and a structured 
consultation schedule would improve the quality of diabetes patient 
care in a diabetic clinic. The introduction of physician education 
programme and structured consultation schedule improved the 
quality of care delivered at the clinics.16 Positive outcome of this 
study should encourage implementation of such programme at all 
diabetes clinics. 







F < 80 = 2,0%
M <94 = 30,8%
BMI (kg/m2)
< 25 = 27,3%
25-29,9 = 35,3%
≥ 30 = 37,3%
Hypertension (mmHg)
SBP ≥ 130 = 78,7% 
DBP ≥ 80 = 59,8%
Total cholesterol (mmol/l)
< 5 = 70,7%
Total triglycerides (mmol/l)
< 1,5 = 54,7%
HDL cholesterol (mmol/l)
> 1,2 = 29,3%
LDL cholesterol (mmol/l)
< 2,5 = 50,7%
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It was not an aim of this study to define the reasons for lack of 
comprehensive care of the diabetes patients at our clinics. There 
are number of possible reasons. SEMDSA guidelines may not be 
adhered to due to lack of knowledge of the recommended targets, 
patient reluctance to comply with treatment, shortage of doctors 
and busy clinics with inadequate staff. However the above are 
merely speculations and now that the sub-optimal care has been 
identified it would be interesting to conduct further studies looking 
into potential causes.
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